PROFUND ADVISORS LLC

Position in PRTA — Prothena Corp Public Ltd Co

CIK 1129919 BETHESDA, MD

Position in PRTA

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$201,380

-$31,948 QoQ

Shares Held

20,570

-14.3% QoQ

Ownership

0.040%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#94

of 187 holders

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. PRTA ranks #152 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$201,380	20,570	-14.3%	Shares	Sole	2026-08-11
2026-03-31	$233,328	24,005	-21.6%	Shares	Sole	2026-04-27
2025-12-31	$292,382	30,616	+101.3%	Shares	Sole	2026-02-06
2024-12-31	$210,686	15,212	+20.1%	Shares	Sole	2025-02-14
2024-09-30	$211,818	12,661	-29.9%	Shares	Sole	2024-11-14
2024-06-30	$373,026	18,073	-61.4%	Shares	Sole	2024-08-13
2024-03-31	$1,161,168	46,878	+38.9%	Shares	Sole	2024-05-08
2023-12-31	$1,226,620	33,754	+26.7%	Shares	Sole	2024-02-14
2023-09-30	$1,285,090	26,634	+20.8%	Shares	Sole	2023-11-13
2023-06-30	$1,505,505	22,049	-16.9%	Shares	Sole	2023-08-10
2023-03-31	$1,285,957	26,531	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.